fbpx
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore exercitation ullamco…
Innovations in Regenerative Medicine

Management Team

MiMedx® has built a management team with highly experienced healthcare executives with track records of leading large healthcare organizations in generating growth, producing profitability, and increasing shareholder value. Our management team draws on guidance from an insightful board of directors and medical advisory board. Collectively, they are committed to achieving success, accomplishing our corporate goals and growing the company. The management team at MiMedx® includes:

Timothy R. Wright
Chief Executive Officer

Mr. Wright was appointed Chief Executive Officer effective May 13, 2019.  Previously, Mr. Wright served as a Partner at Signal Hill Advisors, LLC, a consulting practice, since February 2011. Mr. Wright served as President and Chief Executive Officer of M2Gen Corp., a privately held cancer and health informatics company, between July 2017 and September 2018. […]

Read Full Bio

Edward J. Borkowski
Interim Chief Financial Officer

Mr. Borkowski, was appointed Interim Chief Financial Officer on June 6, 2018. He previously served as Executive Vice President of MiMedx since April 19, 2018.

Read Full Bio

Alexandra O. Haden
General Counsel & Secretary

Ms. Haden has served in the capacity of General Counsel & Secretary since March 1, 2015. Ms. Haden joined MiMedx in June 2013 in the capacity of Senior Attorney.

Read Full Bio

Dr. I. Mark Landy
EVP and Chief Strategy Officer

Dr. Landy was named the Company’s Executive Vice President and Chief Strategy Officer in December 2018. He joined MiMedx in June 2016 as the Company’s Vice President of Strategic Initiatives, bringing a depth of healthcare industry and clinical expertise.

Read Full Bio

Mark P. Graves
Chief Compliance Officer

Mr. Graves joined MiMedx in July 2018 and brings more than 20 years of pharmaceutical and biotech industry experience to the Company, ranging from compliance and sales management to government affairs.

Read Full Bio

David H. Mason, Jr., M.D.
Chief Medical Officer

Dr. Mason was named the Company’s Chief Medical Officer in December 2018. He joined MiMedx in June 2014, in the position of Vice President of Medical Affairs for Clinical Programs. Dr. Mason is a Board Certified Internist, board eligible in Rheumatology and Infectious Diseases, whose experience includes a 27-year pharmaceutical and medical device industry career, […]

Read Full Bio

Thomas J. Koob, PhD
Chief Scientific Officer

Dr. Koob is the Chief Scientific Officer of MiMedx. He is the senior executive responsible for the overall research direction and oversight of the Company’s product and tissue offerings.

Read Full Bio

John D. Harris
Senior Vice President, Marketing and Business Development

Mr. Harris was named Senior Vice President, Marketing and Business Development in December 2018. He joined MiMedx as Senior Vice President, International in June 2018, bringing to the Company 20+ years of experience in the regenerative medicine, medical device and cell therapy fields. In this role, Mr. Harris is responsible for corporate and product marketing, […]

Read Full Bio

Rebeccah J. C. Brown, PhD
Vice President of Product Development, Regulatory Affairs, and Quality Assurance

Dr. Brown joined SpineMedica LLC, an early-stage predecessor company to MiMedx, in 2005. She initially served as the Director of Project Management and Senior Engineer for SpineMedica, and later served as its Director of Research and Development and as Vice President of Operations.

Read Full Bio

Frank Burrows
Vice President of Medical Education

Mr. Burrows joined MiMedx Group in April 2011 as Vice President of Wound Care to lead the marketing of the Company’s wound care offerings and other exciting products and tissues. He assumed the role Of Vice President of Global Marketing in August 2011 to focus on expanding the Company’s presence in the regenerative tissue market.

Read Full Bio

Randall Spencer
Vice President of Clinical Innovation

Mr. Spencer is the co-founder of Surgical Biologics, a leading processor of amnion tissue for use in a variety of surgical implants. Since the founding of Surgical Biologics in 2006, he led the development of the proprietary PURION® Process,

Read Full Bio